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Abstract. The bovine cation-dependent mannose 6-phos- 
phate receptor (CD-MPR) is a type 1 transmembrane 
protein that cycles between the trans-Golgi network, 
endosomes, and the plasma membrane. When the ter- 
minal 40 residues were deleted from the 67-amino acid 
cytoplasmic tail of the CD-MPR, the half-life of the re- 
ceptor was drastically decreased and the mutant recep- 
tor was recovered in lysosomes. Analysis of additional 
cytoplasmic tail truncation mutants and alanine-scan- 
ning mutants implicated amino acids 34-39 as being 
critical for avoidance of lysosomal degradation. The 
cytoplasmic tail of the CD-MPR was partially effective 
in preventing the lysosomal membrane protein Lampl 
from entering lysosomes. Complete exclusion required 
both the CD-MPR cytoplasmic tail and transmembrane 
domain. The transmembrane domain alone had just a 
minor effect on the distribution of Lamp1. These find- 
ings indicate that the cytoplasmic tail of the CD-MPR 
contains a signal that prevents the receptor from traf- 
ficking to lysosomes. The transmembrane domain of 
the CD-MPR also contributes to this function. 
I 
N contrast to proteins that are stable constituents of 
subcellular  organelles,  the recycling  receptors move 
constitutively between compartments. The trafficking 
of these receptors is regulated by sorting signals that are 
recognized at different stages  of the pathway. Studies  of 
the mannose 6-phosphate receptors (MPRs)  1 have proved 
useful  in  identifying some  of  these  signals  (Kornfeld, 
1992). These receptors cycle between the Golgi complex, 
endosomes, and the plasma membrane (Duncan and Korn- 
feld, 1988). The MPRs initially bind newly synthesized ly- 
sosomal enzymes in the TGN. The receptor-ligand com- 
plexes then concentrate in clathrin-coated pits and exit the 
Golgi complex in clathrin-coated vesicles which fuse with 
acidified endosomal/prelysosomal  compartments. The low 
pH of these compartments causes dissociation  of the acid 
hydrolyses that are subsequently packaged into lysosomes. 
The MPRs either recycle  back to the Golgi complex to 
mediate another round of sorting or move to the plasma 
membrane where they are rapidly internalized via plasma 
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membrane clathrin-coated pits. Importantly, the receptors 
avoid being transported from the prelysosomal endosomal 
compartments  to  lysosomes,  whereas  lysosomal  mem- 
brane proteins are delivered efficiently  from endosomes to 
lysosomes. 
Two distinct MPRs have been characterized, the 275-kD 
mannose 6-phosphate/insulin-like growth factor II receptor 
(Man-6-P/IGF-II receptor)  and the 46-kD  cation-depen- 
dent mannose 6-phosphate receptor (CD-MPR). Both are 
type I integral membrane glycoproteins  (Kornfeld, 1992). 
The signals on the MPRs needed for endocytosis from the 
cell surface and efficient incorporation into clathrin-coated 
pits in the TGN reside in the cytoplasmic tails of these pro- 
teins. The signal for the rapid internalization of the Man-6- 
P/IGF-II receptor at the plasma membrane has been local- 
ized to the y26SKV29 sequence in the 163-residue cytoplasmic 
tail (Lobel et al., 1989; Canfield et al., 1991; Jadot et al., 
1992). The CD-MPR contains two distinct signals for rapid 
internalization in its 67-amino acid  cytoplasmic  domain 
(Johnson  et  al.,  1990). One  signal  includes  Phe13  and 
Phel8, while the second signal (which is less potent) in- 
volves Tyr45. Both receptors have dileucine-containing  se- 
quences near  the  carboxyl termini of their cytoplasmic 
tails that are required for efficient entry into Golgi clath- 
rin--coated pits  (Johnson and Kornfeld, 1992a,b; Chen et 
al., 1993). 
In contrast to the sorting steps in the TGN and at the 
cell  surface,  it  is  presently unclear how the  MPRs  are 
sorted in endosomes and avoid degradation in lysosomes. 
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(1992) have postulated that receptor transport from endo- 
somes to the Golgi complex is a constitutive process. Ac- 
cording to this model, movement of membrane proteins 
from endosomes to lysosomes would require a positive sig- 
nal. Some support for this notion has come from the study 
of Green et al.  (1994)  that  demonstrated that P-selectin 
contains a signal in its cytoplasmic tail that is necessary for 
efficient  delivery to  lysosomes. In contrast,  experiments 
with microinjected antibodies specific for the cytoplasmic 
tail of the CD-MPR have led to the suggestion that recy- 
cling from endosomes to the Golgi complex is signal medi- 
ated (Schulze-Garg et al., 1993).  Consistent with this view, 
an immunoelectron microscopy study of HepG2 and BHK 
cells revealed that the  CD-MPR  and the  asialoglycopro- 
tein receptor are sequestered into separate tubular-vesic- 
ular structures associated with endosomes (Klumpermann 
et al.,  1993).  This provides direct evidence for sorting of 
these two receptor types. 
The aim of the present study was to identify the determi- 
nants  that mediate the sorting of the  CD-MPR in endo- 
somes. By analyzing a variety of truncation and alanine-scan- 
ning mutants, we demonstrate that the CD-MPR contains 
a signal that is required to avoid transport to dense lyso- 
somes and subsequent proteolytic degradation. 
Materials and Methods 
Materials 
Enzymes used in molecular cloning were obtained from Boehringer Mann- 
heim Biochemicals (Indianapolis,  IN),  New England Biolabs  (Beverly, 
MA), or  Promega  Corp.  (Madison, WI).  c~-MEM,  Iscove's media,  and 
FBS, as well as Lipofectin were from GIBCO BRL (Grand Island, NY); 
Percoll from Pharmacia Diagnostics AB (Uppsala, Sweden); nitrocellu- 
lose  from Schleicher &  Schuell, Inc.  (Keene,  NH);  protease  inhibitors 
from Sigma Chemical Corp.  (St.  Louis, MO);  enhanced chemilumines- 
cence  Western  blotting  reagents  from  Amersham  Corp.  (Arlington 
Heights,  IL);  Expre3eS3SS label  from NEN  (DuPont  Co.,  Wilmington, 
DE); protein A-Sepharose beads from Repligen Corp. (Cambridge, MA); 
rabbit  anti-mouse IgG  from Zymed Laboratories,  Inc.  (San Francisco, 
CA); FITC goat anti-mouse IgG from Cappel (Organon Teknika Corp., 
Durham, NC);  Permanox multichamber slides from Nunc (Naperville, 
IL); cell culture dishes from Falcon Labware (Becton Dickinson and Co., 
Lincoln Park, NJ). Oligonucleotides were synthesized with a solid phase 
synthesizer (380A; Applied Biosystems, Inc., Foster City, CA) by the Pro- 
tein Chemistry Facility of Washington University. 
Recombinant DNA 
All basic DNA procedures were as described (Sambrook et al., 1989).  A 
cDNA encoding the cytoplasmic tail and transmembrane domain of the 
CD-MPR (Johnson et al., 1990) was subcloned into pBSK- using EcoRI 
and HindlII restriction enzymes to give the plasmid pBSK-MPR  TM°/tail. 
The PCR procedure of Ho et al. (1989) was used to generate the alanine- 
scanning mutants and the MPR C30C34 construct with pBSK- MPR  TMD/tail 
serving as template together with bp 170-193 and 1260-1241 of pBSK as 
the  down-  and  upstream primers.  Appropriate  partial  complementary 
pairs of oligonucleotides in which the desired alanine replacements had 
been incorporated were chosen as internal primers. The final PCR prod- 
ucts were digested with BgllI and MluI, and the purified fragments were 
assembled with the EcoRl-BgllI fragment of pBSK(B-H-)-MPR(BgllI  ) 
(pBSK-MPR that has the BamHI and HindllI sites in its polylinker de- 
leted and the BgllI site at amino acid 112 of CD-MPR destroyed by a si- 
lent point mutation) and the EcoR1-MluI  fragment of pSFFVneo  in a 
three-part ligation. 
Mutants His63Stop, Asp51Stop, and Asp28Stop have been described 
previously (Johnson et al., 1990; Johnson and Kornfeld, 1992b).  The con- 
structs Glu58Stop and Gly54Stop were created as described in Johnson et 
al. (1990). 
The plasmid-encoding human cDNA of Lampl, pDSRa-hlampl (Wil- 
liams and Fukuda, 1990)  was cut with EcoRI, and the fragment was sub- 
cloned into the EcoRI site of the polylinker of pBSK  , resulting in the 
plasmid pBSK-Lampl. Chimeric mutants between CD-MPR and Lampl 
were created using standard PCR protocols with the overlap extension 
technique (Ho et al., 1989). For the construction of LLM and LMM, which 
contain  the  luminal,  transmembrane,  and  cytoplasmic  domains  from 
Lampl (L) or CD-MPR (M) in the order shown, plasmids pBSK-Lampl 
and  pBSK-MPR  TMD/t"il were  used  as  templates  with  bp  1260-1241  of 
pBSK and bp 998-1018 of Lampl as flanking primers. An appropriate 
partial complementary pair of oligonucleotides in which the desired over- 
lap between the Lampl and CD-MPR cDNAs had been incorporated was 
chosen as internal primers. The resulting PCR fragments were cut with 
Eco471II  and XbaI and used to replace the Eco47III-XbaI  fragment of 
pBSK-Lampl. The resulting plasmids were designated pBSK-LMM and 
pBSK-LLM, respectively. The switch from the Lampl to the CD-MPR se- 
quence  was  made  at  T354  (Lampl)  to  L188  (CD-MPR),  and  G378 
(Lampl) to Q213 (CD-MPR) to create the chimeras LMM and LLM, re- 
spectively. To  construct the  chimera  LML plasmids, pBSK-LMM  and 
pBKS(B-H  )-MML were used as templates for the PCR, bp 998-1018 of 
Lampl and bp 1260-1241 of pBSK were used as flanking primers, and in- 
ternal primers were chosen as described above. The PCR product was di- 
gested with Eco47111 and XbaI to replace the corresponding fragment of 
pBSK-Lampl generating the plasmid pBSK-LML. The plasmids pBSK- 
LLM, pBSK-LMM, and PBSK-LML were cut with EcoRI and ligated into 
pSFFVneo (Fuhlbridge et al., 1988; Johnson et al., 1990)  resulting in the 
final plasmids used for transfection. 
The final plasmids were sequenced using the Sanger dideoxy chain ter- 
mination method (Sanger et al., 1977) to verify that the mutant constructs 
were correct. 
Cell Culture and Transfection 
A  Man-6-P/IGF-II receptor-deficient  mouse L  cell line  designated D9 
(LRec-)  was maintained in (~-MEM)  containing 10%  heat-inactivated 
FBS, 100 U/ml penicillin, and 100 ~g/ml streptomycin at 37°C in a 5 % hu- 
midified CO2 atmosphere (Gabel et al., 1983).  The cells were transfected 
with 20 ~g of Xbal-linearized DNA using Lipofectin (GIBCO BRL) ac- 
cording to the manufacturer's directions. Selection for resistance to neo- 
mycin (G418) was as described previously (Lobel et al,, 1989) except that 
the  final  G418  concentration  was  500  txg/ml.  Resistant colonies  were 
screened  for  expression by  immunoblotfing. Selected  clones were  ex- 
panded for further study and maintained in selective medium. 
Antibodies 
mAb G1/139 against human Lampl (Schweizer et al.,  1988)  and rabbit 
polyclonal antisera 931-A against human Lampl (Carlsson et al., 1988) 
were kind gifts of Dr. H.-P. Hauri (Biozentrum, Basel, Switzerland) and 
Dr.  M.  Fukuda  (Cancer  Research Center,  La Jolla,  CA),  respectively. 
mAb 22D4 specific for the bovine CD-MPR was generously provided by 
Dr. D. Messner (Messner, 1993). 
Confocal Immunofluorescence Microscopy 
Ceils were grown in eight-well Permanox multichamber slides. The immu- 
nofluorescence procedure for permeabilized cells was that of Schweizer et 
al. (1988).  In brief, formaldehyde-fixed and saponin-permeabilized cells 
were incubated with mAb G1/139 against Lamp1 or mAb 22D4 against 
CD-MPR followed by goat anti-mouse FITC. The specimens were exam- 
ined with a confocal laser scanning microscope system (MRC 1000; Bio- 
Rad Laboratories, Hercules, CA) attached to a  microscope (Carl Zeiss, 
Inc., Thornwood, NY). 
Percoll Gradient Fractionation 
Confluent ceils grown in a 100-ram petri dish were incubated for either 12 
or 24 h in growth medium supplemented with 100 p,M each of pepstatin A 
and leupeptin. After two washes with PBS, the cells were scraped into 2 
ml of homogenization buffer (HB) (0.25 M sucrose, 1 mM EDTA, pH 7.5) 
and centrifuged for 10 rain at 140 g. The cells were resuspended in 850 p,l 
of HB, and passed 12 times through a  ball bearing homogenizer (Balch 
and Rothman, 1985) with a clearance of 51.2 p~m. The homogenate was di- 
luted with an additional 850 ~l HB, and centrifuged for 10 min at 400 g. 
The resulting postnuclear supernatant was layered over a  discontinuous 
gradient consisting of a 1.2-ml cushion of 10 ×  HB and 8.5 ml of an 18% 
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20,000 rpm in a Ti 50 rotor (Beckman Instruments Inc., Palo Alto, CA). 
The cushion followed by nine 1.2-mL fractions were collected from the 
bottom of the tube. For initial determinations of the 13-hexosaminidase 
distribution, fractions 1-9 were processed individually. In subsequent ex- 
periments, the gradient fractions were combined as follows: fractions 1-3 
(pool I), fractions 4-6 (pool II), and fractions 7-9 (pool III). The Percoll 
was removed by centrifugation twice for 30 min at 85,000 rpm in a  TL 
100.3  rotor (Beckman Instruments Inc.). The pelleted membranes were 
transferred into 1.5-ml ultracentrifugation tubes, diluted with HB to a fi- 
nal vol of 1 ml, and centrifuged for an additional 50 min at 70,000 rpm in 
the TL  100.3  rotor  to  remove the  remaining Percoll.  The  sedimented 
membranes were transferred into 1.5-ml tubes and mixed with HB to a fi- 
nal vol of 300 ixl. The samples were adjusted to 0.5% Triton X-100, passed 
five times through a 25-gauge needle connected to a 1-ml syringe, and sol- 
ubilized on ice for 30 rain. An aliquot corresponding to 1/10 of the total 
volume was removed for the 13-hexosaminidase assay. 300 p,1 of 3:< elec- 
trophoresis sample buffer (1.875  mM Tris-HC1, pH 6.8,  6%  SDS,  30% 
glycerol, 0.003% bromophenol blue) with (for detection with anti-Lampl 
mAb) or without (for detection with anti-CD-MPR mAb) 0.3 M DTT was 
added to the remaining sample and the mixture was boiled for 3 min. Ali- 
quots (1/30 for analysis with anti-Lampl mAb, and 1/15 for analysis with 
anti CD-MPR mAb) of the final sample volume were analyzed by SDS- 
PAGE and immunoblotting. 
SDS-PA  GE, Fluorography, and Immunoblotting 
Proteins  were  separated  on  6  and  10%  SDS-polyacrylamide  minigels 
(Bio-Rad Laboratories) using the Laemmli (1970) system. After electro- 
phoresis, gels were either treated with Amplify, dried, and exposed to film 
XOmat AR; Eastman Kodak Co., Rochester, NY) (time course), or trans- 
ferred onto nitrocellulose membranes according to the method of Towbin 
et al. (1979)  (Percoll density fractionation).The nitrocellulose sheet was 
blocked with 3%  nonfat dry milk powder (Schnucks, St.  Louis, MO) in 
PBS.  The  blot  was  subsequently incubated  with  mAb  G1/139  against 
Lamp1 (diluted 1:1,000 in PBS-3% powdered milk) or mAb 22D4 (diluted 
1:500 in PBS-3% powdered milk) followed by an HRP-conjugated anti- 
mouse secondary antibody (Amersham Corp.). Immunoreactive proteins 
were visualized using the enhanced chemiluminescence detection system 
according to the manufacturer's directions. The autoradiograph was quan- 
titated using a personal densitometer (Molecular Dynamics, Inc., Sunny- 
vale, CA). 
Enzyme Assays 
[3-hexosaminidase activity was determined by dilution of the samples in 
1.67 mM p-nitrophenyl N-acetyl-13-glucosaminide, 50 mM citrate, pH 4.5, 
0.1% Triton X-100. The samples were incubated for 30-450 min at 37°C; 
the reaction was stopped with 0.2 M  sodium carbonate,  and the absor- 
bance read at 400 nm. 
Determination of Receptor Half-Lives 
Confluent cells grown in six-well plates were rinsed twice with PBS and 
preincubated in methionine- and cysteine-free growth medium containing 
10% dialyzed FCS and 20 mM Hepes, pH 7.4, for 30 min. The cells were 
then incubated for 60 min with 100 txCi of EXPRE35S35S  protein-labeling 
mixture in preincubation medium, and chased in normal culture medium 
in the presence of 10 mM unlabeled methionine for 0-24 h. For the 24-h 
time point, duplicate wells were incubated in the absence or presence of 
100 IxM of pepstatin A  and leupeptin. At the end of the chase, ceils were 
chilled on ice, washed twice with 2 ml ice-cold PBS, scraped into 2 ml ice- 
cold PBS, and centrifuged for 10 min at  140 g.  The pellets were resus- 
pended in buffer II (10 mM sodium phosphate, pH 8.0, containing 1% Tri- 
ton X-100 and a  1:500 dilution of a protease inhibitor cocktail (5 mg/ml 
benzamidine, and 1 Ixg/ml each of pepstatin A, leupeptin, antipain, and 
chymostatin in 40%  dimethyl sulfoxide-60% ethanol))  and passed five 
times through a 25-gauge needle connected to a 1-ml syringe. After incu- 
bating for 1 h on ice, the cell lysates were centrifuged for 60 rain at 40,000 
rpm in a Ti 50 rotor. The resulting supernatants were collected and used 
for  immunoprecipitation. Wild-type  and  mutant  CD-MPR  proteins,  as 
well as chimeric proteins containing the CD-MPR luminal domain, were 
immunoprecipitated with mAb 22D4, while the rabbit antiserum against 
lamp1 was used for the immunoprecipitation of lamp1 and chimeric pro- 
teins with a  lamp1 luminal domain. For immunoprecipitation with anti- 
CD-MPR mAb 22D4, 25  txl of protein  A-Sepharose was washed once 
with 1 ml 100 mM sodium phosphate-0.2% BSA, pH 8.0 (buffer I), and 
then incubated with 2 V.1 rabbit anti-mouse antibody (1 mg/ml) in 500 ~1 
buffer I for 2 h at room temperature. After two washes with buffer I, the 
beads were incubated with 20 i~1 of mAb 22D4 in 500 txl buffer I overnight 
at 4°C. For immunoprecipitation with anti-lampl polyclonal antibodies, 
the washed protein A-Sepharose beads were directly incubated with 2 tll 
antiserum overnight at 4°C. The beads were then washed twice with 1 ml 
buffer I and once with 1 ml buffer II. The washed beads and radiolabeled 
cell lysates were combined and incubated overnight at 4°C with constant 
mixing.The protein A-Sepharose beads were pelleted, washed four times 
with buffer II, and then once with 100 mM sodium phosphate, pH 8.0, fol- 
lowed by a final wash step with 10 mM sodium phosphate, pH 8.0. The im- 
munocomplexes were released from the beads by boiling for 3 min in elec- 
trophoresis sample buffer containing 62.5 mM Tris-HC1, pH 6.8, 2% SDS, 
10% glycerol, 0.001% bromophenol blue, and 0.1 M DTT. 
Cell Surface Biotinylation 
Confluent cells grown in  six-well plates were  labeled  for  30  min with 
Expre35S35S and chased for 0 min, 30 rain, 1 h, or 8 h as described above. 
Cell monolayers were then washed twice with ice-cold PBS followed by 
five wash steps with PBS supplemented with 0.7 mM CaC12 and 0.25 mM 
MgSO2  (PBS++)over  a  period  of 30  min  before  NHS-SS-biotin  was 
added at a concentration of 3 mg/ml in PBS  2+ for 45 min on ice. Biotinyla- 
tion was stopped by washing four times with 50 mM glycine in PBS  2+. The 
cells were lysed in buffer II and centrifuged for 1 h at 100,000 g in a Ti 50 
rotor. The resulting supernatants were immunoprecipitated as described 
above. 
Results 
Cytoplasmic Tail of the CD-MPR Contains 
a Signal that Prevents Delivery of the Receptor to 
Dense Lysosomes 
To test for a possible endosomal sorting signal in the cyto- 
plasmic tail of the CD-MPR, we analyzed a truncated form 
of the receptor (Asp28Stop) that has amino acids 28-67 of 
the  cytoplasmic tail  deleted  (Johnson  et  al.,  1990).  Al- 
though  Asp28Stop  lacks  a  Golgi  sorting  signal,  it  effi- 
ciently enters the endosomal system via the plasma mem- 
brane by endocytosis (Johnson et al.,  1990; Johnson and 
Kornfeld,  1992).  We  first  determined  the  half-life  of 
Asp28Stop  in  mouse  L  cells stably expressing the  trun- 
cated  receptor. In  these  experiments, the  cells were  la- 
35  beled with [  S]methionine/cysteine for 1 h and chased for 
various time periods either in the absence or presence of 
the lysosomal protease inhibitors pepstatin A  and leupep- 
tin. Cells expressing the wild-type bovine CD-MPR served 
as  the  control.The CD-MPRs  were  immunoprecipitated 
from cell lysates with mAb 22D4, analyzed by SDS-PAGE 
and fluorography, and quantitated by scanning densitome- 
try. The gels from a typical experiment are shown in Fig. 1, 
A and B, with the data from multiple experiments summa- 
rized in C. The CD-MPR and Asp28Stop were synthesized 
as  40-  and  35-kD  precursor  forms,  respectively,  which 
were converted to 46- and 41-kD  mature  forms by 4 h. 
This indicates that these polypeptides were transported to 
the Golgi apparatus and underwent N-linked oligosaccha- 
ride processing with similar kinetics (Gasa and Kornfeld, 
1987).  The half-life of the CD-MPR was  >40 h.  In con- 
trast, the half-life of Asp28Stop was reduced by more than 
fourfold (tl/2  =  10 h). The degradation of the truncated re- 
ceptor was completely blocked by pepstatin A and leupep- 
tin. This protection is consistent with the receptor being 
degraded in lysosomes. 
To confirm morphologically that  the  mutant  receptor 
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Asp28Stop  receptors. Mouse L cells stably expressing CD-MPR 
(A) or Asp28Stop  (B) were metabolically  labeled with  [35S]me- 
thionine/cysteine  and chased for the indicated time intervals. The 
24-h time point was  performed with  or without  the lysosomal 
protease inhibitors pepstatin A and leupeptin (Pep./Leup.). Wild- 
type  and  mutant  receptors  were  immunoprecipitated  with 
mAb22D4 and analyzed  by SDS-PAGE (10%  gels). The num- 
bers on the right margin of the gel indicate the migration of mo- 
lecular  mass standards  in kilodaltons.  Schematic  illustrations  of 
the constructs  are shown underneath each autoradiograph. (C) 
The autoradiographs shown in A and B as well as those from ad- 
ditional experiments,  were quantitated by scanning densitometry. 
At  each time point  the  amount  of wild-type  receptor  (O)  or 
Asp28Stop  ([3) detected is plotted as the percentage of the value 
obtained at the 4-h chase point. The 24-h time point in the pres- 
ence of pepstatin A and leupeptin is indicated  by O* (CD-MPR) 
and N* (Asp28Stop), respectively. 
was being transported to lysosomes, we analyzed the local- 
ization of the Asp28Stop receptor by confocal immunoflu- 
orescence microscopy. For this  purpose,  stable cell lines 
expressing either CD-MPR, Asp28Stop, or the lysosomal 
membrane protein Lamp1 were preincubated for 12 h  in 
the  presence  or  absence  of pepstatin  A  and  leupeptin, 
fixed with paraformaldehyde, permeabilized with saponin, 
and stained with appropriate antibodies. As expected, the 
CD-MPR  showed  a  predominant  perinuclear  staining, 
representing localization in the TGN and late endosome/ 
prelysosomal compartments, as well as staining of vesicles 
(early endosomes) and, to a lesser extent, the cell surface 
(Fig. 2, A  and B). The fluorescence pattern of Lamp1 with 
its ringlike structures was characteristic for lysosomal stain- 
ing (Fig. 2, E  and F). The staining pattern of Asp28Stop in 
the  mock-treated cells was very similar to that  observed 
for  CD-MPR  (Fig.  2  C).  However,  the  distribution  of 
Asp28Stop  in  cells pretreated  with pepstatin A  and  leu- 
peptin was similar to Lampl, indicating that the truncated 
receptor was being degraded in lysosomes (Fig. 2 D). 
Figure  2.  Confocal  immunofluorescence  localization  of  CD- 
MPR,  Asp28Stop,  and Lampl. Cell lines stably expressing  CD- 
MPR (A and B), Asp28Stop  (C and D), and Lampl (E and F) 
were either preincubated for 12 h with pepstatin A and leupeptin 
(B, D, and F) or mock-treated (A, C, and E) before fixation with 
paraformaldehyde and permeabilization with saponin. For detec- 
tion mAb 22D4 (A-D) or mAb G1/139 (E and F) followed by 
goat anti-mouse FITC were used. The pictures  represent linear 
projections of several optical sections. Bar, 7.5 Ixm. 
The lysosomal distribution of the mutant Asp28Stop re- 
ceptor was further  documented  using isoosmotic Percoll 
density gradients that separate dense lysosomes from other 
organelles  (Green  et  al.,  1987).  Cell  monolayers  were 
grown in culture media supplemented with pepstatin A and 
leupeptin for either 12 or 24 h. Fig. 3 A  shows the typical 
distribution of the lysosomal enzyme marker 13-hexosamini- 
dase on Percoll gradients using cells stably expressing CD- 
MPR  or  Lampl.  The  majority of the  [3-hexosaminidase 
activity was recovered at the bottom of the gradient, well- 
separated  from  lighter  membranes  that  accumulated  in 
fractions 7-9 (data not shown,  Green et al.,  1987).  Based 
on this  distribution,  the  fractions were  analyzed in three 
pools in all subsequent experiments: pool I (fractions 1-3) 
containing the bulk of lysosomal enzyme activity (70--80 %); 
pool  II  (fractions  4-6)  containing  intermediate  density 
membranes;  and  pool  III (fractions  7-9)  containing  low 
density membranes including endosomes, Golgi complex, 
plasma membrane, and the ER (Green et al., 1987). 
The  distribution  of  the  CD-MPR,  Asp28Stop,  and 
Lampl was determined by electrophoresis of the Percoll 
density fractions followed by Western blotting  (Fig.  3, B 
and  C, for quantitation).  The CD-MPR was excluded al- 
most completely from the dense lysosome fraction (4% re- 
covered in pool I) whereas 62-68%  of Lampl was recov- 
ered in pool I. After the 12-h incubation with pepstatin A 
and  leupeptin,  24  --- 5%  of Asp28Stop was recovered in 
the dense lysosome fraction and this value increased to 44 
-  6%  after 24 h  of incubation with the inhibitors.  These 
data further corroborate the lysosomal distribution of the 
Asp28Stop receptor. 
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Lampl  on  Percoll  density  gradients.  Cells  were  homogenized 
with  a  ball  bearing  homogenizer and  postnuclear supernatants 
were subjected to Percoll density gradient centrifugation (18% 
Percoll). (A) Percoll gradient fractions of mouse L cells stably ex- 
pressing  either  CD-MPR (0)  or Lampl  (D)  were  assayed for 
[3-hexosaminidase  activity.  The value for each fraction was ex- 
pressed as its percentage of the total activity recovered from the 
gradient.  For further experiments the fractions were combined 
into pool I, II, and III as indicated below the marker profile. (B) 
Mouse L cells stably expressing CD-MPR, Asp28Stop, or Lampl 
were preincubated for 24 h with pepstatin A and leupeptin, and 
subjected to fractionation as described above. Proteins of pool I, 
II, and  III were  analyzed by SDS-PAGE and  immunoblotting 
with  mAb  22D4  (CD-MPR,  Asp28Stop)  or  mAb  G1/139 
(Lampl). (C) The immunoblots shown in B and those from addi- 
tional experiments were quantitated. Preincubation with pepsta- 
tin A and leupeptin was for 12 or 24 h as indicated. For each con- 
struct (x-axis)  the value of pool I (dense lysosomes, filled bars) 
and the values of pools II and III combined (striated bars) were 
expressed as their percentage of the total value of all three pools 
(y-axis). 
Upon examining the sequence of the cytoplasmic tail of 
Asp28Stop, we noted that the truncation  exposed  a  Leu- 
ValAla sequence at the carboxyl terminus.  Since a  Leulle 
sequence in the cytoplasmic tail of LimpII has been shown 
to direct this membrane protein to lysosomes (Ogata and 
Fukuda,  1994;  Sandoval  et  al.,  1994),  we  considered  the 
possibility  that  a  lysosomal targeting  signal was inadver- 
tently unmasked in the deletion mutant. Therefore a con- 
struct was prepared  (Leu25Ala Asp28Stop)  in which the 
leucine at position 25 was mutated to an alanine. This mu- 
tation  in  LimplI prevents  targeting  to lysosomes  (Ogata 
and Fukuda, 1994; Sandoval et al., 1994). When L cells ex- 
pressing  Leu25Ala  Asp28Stop  were  analyzed by Percoll 
gradient  fractionation  after  24  h  of incubation  with  pro- 
tease inhibitors,  56  --- 5%  of the mutant receptor was re- 
covered in dense lysosomes (Table I). This result excludes 
the possibility that the exposed LeuValAla sequence was 
serving as a positive lysosomal targeting signal. 
Taken  together,  these  results  indicate  that  the  deleted 
portion of the cytoplasmic tail of the CD-MPR contains a 
signal  to  prevent  the  receptor  from  entering  lysosomes 
and being degraded. 
Effect of Different Cytoplasmic Domain Deletions on 
Receptor Degradation 
We next analyzed the effect of truncating increasing por- 
tions of the COOH-terminal region of the CD-MPR cyto- 
plasmic tail on the accumulation of the receptor in dense 
lysosomes. Stable clones of L cells that had been transfected 
with  cDNAs  encoding  mutant  CD-MPRs  containing  62 
amino  acids  (His63Stop),  57  amino  acids  (Glu58Stop)  53 
amino acids (Gly54Stop), and 50 amino acids (Asp51Stop) 
of the 67-amino acid cytoplasmic tail were studied (Fig. 4 
A). The cells were incubated with pepstatin A  and leupep- 
tin for 24 h  and then cell lysates were analyzed on Percoll 
gradients. As summarized in Fig. 4 B and Table I, the dele- 
tion of 5 (His63Stop) or 10 (Glu58 Stop) amino acids from 
the carboxyl terminus of the cytoplasmic tail did not result 
Table 1. Summary of Results of Percoll Density Gradients 
Percentage in 
Mutant  dense lysosomes 
CD-MPR  4  -+  1 
4+--3  * 
Asp28Stop  44 --- 6 
24 --- 5* 
Leu25Ala Asp28Stop  56 +-5 
Asp51 Stop  26+-- 5 
Gly54Stop  14 +- 3 
Glu58Stop  6  -+  1 
His63Stop  4  ~  3 
MPR 28-33A  5  +-  1 
MPR 34-39A  30 +- 3 
MPR 40-45A  6  +- 2 
MPR 46-50A  4  --- 2 
MPR 35-39A  27 -  3 
MPR 34-36A  16 --- 4 
MPR 37-39A  16 +-- 3 
MPR C30C34A  30 +- 2 
LLM  33 --- 7* 
LMM  11  -  11" 
LML  50 +-  10" 
Lampl  68 --- 7 
62 +-  ll* 
All experiments were performed after a 24-h preincubation with pepstatin A and leu- 
peptin, except for those indicated by the *, where the preincubation was for 12 h. Val- 
ues are the average of 3 to 10 separate experiments. 
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cated in Fig. 5 A, amino acids 28--33 (MPR 28-33A), 34-39 
(MPR  34-39A),  40-45  (MPR  40-45A),  or  46-50  (MPR 
46-50A) were changed to alanines using PCR mutagene- 
sis. When L cells stably expressing these various constructs 
were  incubated with pepstatin A  and  leupeptin for 24  h 
and  analyzed  on  Percoll gradients,  the  mutant  receptor 
containing alanine residues in positions 34-39 of the cyto- 
plasmic tail was found to accumulate in dense lysosomes 
(30  +  3%)  whereas the other three mutant receptors did 
not  (Fig.  5,  B  and  C,  for  quantitation,  and  Table  I).  It 
should be noted that even though constructs MPR 40-45 
and  46-50  have  the Tyr-based internalization signal mu- 
tated, these receptors still undergo rapid endocytosis due 
to  the  presence  of  the  Phe-based  internalization  signal 
(Johnson et al., 1990). These results suggest that amino ac- 
ids 34-39 within the cytoplasmic tail of the CD-MPR play 
an important role in preventing lysosomal targeting of the 
receptor. 
Figure 4.  Effect of tail length on receptor targeting. (A) Sche- 
matic illustration of the cytoplasmic tails of CD-MPR and trunca- 
tion mutants.  Bars represent wild-type and mutant cytoplasmic 
tails. The numbers at the right margin of truncated tails indicate 
the position of the stop codons. (B) Mouse L cells stably express- 
ing His63Stop, Glu58Stop, Gly54Stop, andAsp51Stop were pre- 
incubated with pepstatin A and leupeptin for 24 h and then frac- 
tionated as described in Fig. 3. Proteins of pool I, II, and III were 
subjected to SDS-PAGE and immunoblotting with mAb 22D4. 
The quantitation of several experiments is shown. For each con- 
struct the value of pool I  (dense lysosomes, filled bars) and the 
values of pools II and III combined (striated bars) were expressed 
as their percentage of the total value of all three pools. The distri- 
bution of CD-MPR and Asp28Stop from Fig. 3 is given for com- 
parison. 
in significant accumulation of receptor in dense lysosomes. 
Deletion of 14 amino acids (Gly54Stop) resulted in a mod- 
est  accumulation  of receptors in  dense  lysosomes (14  _ 
3%) whereas the deletion of 17 amino acids (Asp51Stop) 
had  a  more  profound  effect  (26  ---  5%  accumulation  in 
dense  lysosomes).  However,  this  accumulation  was  less 
than that observed with Asp28Stop after 24 h  of pepstatin 
A  and  leupeptin  treatment  (44  ---  6%  accumulation). 
These experiments indicated that amino acid residues 28-57 
are required to prevent targeting of the receptor to dense 
lysosomes and within this sequence, residues 28-50 appear 
to be most important. 
Replacement of  Amino Acid Residues 34-39 
of the Cytoplasmic Tail Leads to Rapid Degradation 
in Lysosomes 
To define more precisely the determinants present within 
the amino acid 28-50 region of the CD-MPR cytoplasmic 
Figure 5.  Amino acids 34-39 in the cytoplasmic tail of CD-MPR 
are critical for receptor targeting. (A) Schematic illustration of 
alanine scanning mutants within the cytoplasmic tail of CD-MPR. 
The bar represents the cytoplasmic  tail of CD-MPR and the num- 
bers indicate individual amino acid positions. The wild-type se- 
quence of amino acids 28-50 is shown underneath the bar. Amino 
acids 28-33 (MPR 28-33A), 34-39 (MPR 34-39), 40--45 (MPR 
40-45A), and 46-50 (MPR 46-50A) were substituted by alanines 
as indicated. (B) Mouse L cells stably expressing MPR 28-33A, 
MPR 34-39A, MPR  4~45A,  and  MPR  46-50A were  preincu- 
bated with pepstatin A  and leupeptin for 24 h and then fraction- 
ated as described in Fig. 3. Proteins of pool I, II, and III were sub- 
jected to SDS-PAGE and immunoblotting with mAb 22D4. (C) 
Quantitation of the immunoblots shown in B and those from ad- 
ditional experiments. The values were calculated as described in 
Fig. 3. Filled bars, pool I (dense lysosomes); striated bars, pools II 
and III combined. 
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ments  of subsets  of the residues  34-39  (CRSKPR) were 
prepared to dissect further the role of this region of the cy- 
toplasmic tail.  An additional construct was made in which 
the two cysteines present in the cytoplasmic tail  at posi- 
tions 30 and 34 were changed to alanines. As summarized 
in Table I, MPR 35-39A and MPR C30C34A accumulated 
in dense lysosomes to the same extent as MPR 34-39A (27 
+  3 and 30 +- 2%, respectively, versus 30 _+ 3%). The mu- 
tant receptors MPR 34-36A and MPR 37-39A exhibited 
somewhat less  accumulation in dense lysosomes (16  +  4 
and  16  -+  3%, respectively). These findings indicate that 
multiple residues in the amino acid 34-39 sequence are in- 
volved in preventing the receptor from trafficking to lyso- 
somes. 
Cytoplasmic Tail and Transmembrane Domain of 
CD-MPR Are Sufficient for Endosomal Sorting 
The results  with the  cytoplasmic tail  truncation and  ala- 
nine-scanning  mutants  established  that  the  cytoplasmic 
tail of the CD-MPR is necessary for avoiding delivery to 
dense lysosomes. To determine whether this domain is suf- 
ficient to exclude a lysosomal membrane protein from be- 
ing targeted to lysosomes, we created a chimeric molecule, 
LLM, containing the luminal and transmembrane domains 
of Lamp1 with the cytoplasmic tail of the CD-MPR. Two 
additional  constructs  LMM  (luminal  domain  of Lamp1, 
transmembrane  and  cytoplasmic  domains  of  CD-MPR) 
and  LML (luminal  and  cytoplasmic domains  of Lamp1, 
transmembrane  domain of CD-MPR) were generated to 
evaluate  the  role  of the  transmembrane  domain  of the 
CD-MPR in this sorting event. When L  cells transfected 
with  these  various  constructs  were  analyzed  on  Percoll 
gradients, only 33 -+ 7% of the chimeric LLM protein was 
recovered in  the  dense  lysosome fraction  (pool I)  com- 
pared with 62 +_ 11% of Lamp1 (Fig.  6). Even less of the 
LMM  protein  was  recovered in  dense  lysosomes (11  -+ 
11%). The localization of the LML protein was similar to 
that obtained with Lamp1, with 50 +_  10%  of the protein 
being recovered in dense lysosomes. 
To exclude the possibility that the amount of LMM and 
LLM chimeras present  in  dense  lysosomes was reduced 
due to mislocalization to the plasma membrane, we deter- 
mined the fraction of the chimeric molecules at the  cell 
surface. Cell lines expressing the various constructs were 
labeled for 30 min with [35S]methionine/cysteine  and chased 
for up to 8 h. After the chase period, the surface appear- 
ance of the chimeric proteins was detected by biotinyla- 
tion of intact cells with the membrane-impermeable probe 
NHS-SS-biotin on ice. The cells were solubilized and total 
LMM, LLM, or Lamp1 immunoprecipitated with a rabbit 
anti-human Lamp1 antibody. The resultant immunocom- 
plexes were dissociated and divided into two aliquots. Bio- 
tinylated  (surface)  molecules  were  reprecipitated  from 
three-quarters  of the  sample  using  streptavidin-agarose 
beads, and the remaining quarter was used to determine 
the total amount of labeled protein. The two samples were 
then  analyzed by SDS-PAGE, and  quantitated  by scan- 
ning densitometry to give values for the total and surface 
molecules. The results of a typical experiment are shown 
in Fig. 7 A  with the quantitation of multiple experiments 
given in Fig. 7 B.  Only 3% of Lamp1 was detected at the 
cell surface after 1 h of chase, and by 3 h of chase Lamp1 
Figure 6.  Distribution of LMM, LLM, and LML on Percoll gradi- 
ents. Mouse L cells stably expressing LMM, LLM, and LML were 
analyzed as described in Fig. 3. (A) Proteins of pool I, II, and III 
were subjected to SDS-PAGE and immunobloting with mAb G1/ 
139. A schematic illustration of each construct is shown under- 
neath each autoradiograph  (luminal domain, left box; transmem- 
brane domain, middle box; cytoplasmic tail, right box). (B) Quan- 
titation  of  the  immunoblots  shown  in  A  and  those  from 
additional experiments. The values were calculated as described 
in Fig. 3. Filled bars, pool I (dense lysosomes); striated bars, pools 
II and III combined. The distribution of Lampl of Fig. 3 is shown 
for comparison. 
was undetectable at the surface. This is similar to the re- 
suits of Harter and Mellman (1990).  Surface appearance of 
LMM was also transient, reaching a maximum of 8% after 
3 h  and almost disappearing at 8 h. A  greater fraction of 
LLM appeared at the cell surface (21% after 3 h), but after 
8 h  only 6%  of the protein remained on the cell surface. 
These data show that LMM and LLM do not accumulate 
in the plasma membrane. These results support our con- 
tention that the cytoplasmic tail and transmembrane do- 
main of the CD-MPR are important in preventing lysoso- 
real targeting of the receptor. 
Discussion 
Previous  studies  have  identified  short  amino  acid  se- 
quences in the cytoplasmic tail of the CD-MPR that medi- 
ate rapid internalization at the plasma membrane and effi- 
cient entry into Golgi clathrin-coated pits (Johnson et al., 
1990; Johnson and Kornfeld, 1992b).  One internalization 
signal included Phe13 and Phe18, while a second, less po- 
tent internalization signal involved Tyr45. The Golgi sort- 
ing signal included the LeuLeu sequence near the carboxyl 
terminus  of  the  cytoplasmic tail.  The  results  presented 
here  demonstrate  that  the  cytoplasmic tail  of the  CD- 
MPR contains yet a third signal which functions to prevent 
the receptor from trafficking to lysosomes where it would 
be degraded.  In addition, the transmembrane  domain of 
the CD-MPR also contributes to this function. 
The most direct evidence that this effect is mediated by 
a positive sorting signal within the cytoplasmic tail of the 
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and LMM.  (A) Mouse L  cells stably expressing  Lampl, LLM, 
and LMM were labeled with [35S]methionine/cysteine for 30 min 
and then chased for the indicated  times. At each time point, la- 
beled cell surface proteins were derivatized using NHS-SS-biotin. 
The cells were lysed and surface biotinylated,  and internal Lampl 
and chimeric  molecules  were immunoprecipitated using a poly- 
clonal anti-Lampl antibody (931-A). After solubilization  of the 
first immunoprecipitate, three-quarters of each sample was incu- 
bated with streptavidin  beads to precipitate surface biotinylated 
molecules. All precipitates  were analyzed by SDS-PAGE and au- 
toradiography. (B) Autoradiographs shown in A and those from 
additional  experiments were quantitated by scanning densitome- 
try. The values presented in the graph represent the percentage 
of Lampl (x), LLM (t) and LMM (A) detected at the cell sur- 
face relative to the total amount detected at a given time point. 
CD-MPR comes from the  analysis of the truncation  mu- 
tants  Asp28Stop  and  Leu25Ala  Asp28Stop  that  have 
amino acids 28--67 of the tail deleted. These mutant recep- 
tors accumulate in lysosomes as judged by three different 
criteria:  first,  a  sharply  reduced  half-life  with  complete 
protection from degradation by the lysosomal protease in- 
hibitors,  pepstatin A  and  leupeptin;  second,  a  lysosomal 
immunofluorescence  pattern;  and  third,  the  recovery of 
the  truncated  receptors in  the  dense lysosomal fractions 
on  Percoll  density  gradients.  These  results  indicate  that 
amino acids 28-67 of the cytoplasmic tail contain sorting 
information  that  is  necessary to  keep the  receptor from 
being transported to lysosomes. Subsequent analysis of ad- 
ditional truncation mutants localized the signal to amino 
acid residues 28-50 and alanine scanning of this region im- 
plicated amino acids 34-39 as being most critical. Within 
this segment, multiple residues appear to be required.  A 
search of the GenBank database, which includes other re- 
cycling receptors, failed to reveal any strong homologies 
with  the  sequence  CysArgSerLysProArg.  However,  the 
Man-6-P/IGFII receptor does  contain  a  CysCysArgArg- 
Ser sequence in its cytoplasmic tail, but its significance is 
currently unknown. 
While the cytoplasmic tail of the CD-MPR is necessary 
for proper sorting of the receptor in endosomes, it is only 
partially effective in preventing the lysosomal membrane 
protein Lampl from entering lysosomes. Complete exclu- 
sion required the combined presence of the CD-MPR cy- 
toplasmic tail  and  transmembrane  domain,  even though 
the transmembrane domain alone had just a minor effect 
on the distribution of Lamp1. The latter result also dem- 
onstrated that the transmembrane domain of Lampl is not 
absolutely required for the proper localization of that pro- 
tein in lysosomes. The finding that  both the  cytoplasmic 
tail and the transmembrane domain of the  CD-MPR are 
required  for proper sorting in  endosomes differs from a 
number of other sorting events, including sorting of recep- 
tors into plasma membrane and Golgi clathrin-coated pits, 
where signals on the cytoplasmic tail alone are sufficient to 
mediate the process. On the other hand, the luminal do- 
main of the CD-MPR does not appear to be necessary for 
proper endosomal sorting as indicated by the finding that 
construct LMM had a  distribution very similar to that of 
native CD-MPR. Furthermore, the luminal domain of the 
CD-MPR is not sufficient to prevent the delivery of the re- 
ceptor to lysosomes, as shown by our data and the study of 
Peters et al.  (1990).  These investigators found that a  chi- 
mera  containing  the  luminal  domain  of  the  CD-MPR 
fused to the transmembrane domain and cytoplasmic tail 
of lysosomal acid phosphatase is rapidly transported to ly- 
sosomes. This is of interest since the luminal domain of the 
Man-6-P/IGF-II receptor has been reported to be essential 
for proper trafficking of this receptor (Dintzis and Pfeffer, 
1990;  Dintzis  et  al.,  1994;  Conibear  and  Pearse,  1994). 
Dintzis and her colleagues (1990; 1994) found that a chimeric 
molecule in which the luminal domain of the Man-6-P/IGF- 
II receptor was replaced by the corresponding domain of 
the  EGF  receptor  localized  to  the  plasma  membrane, 
while the opposite chimera containing the luminal domain 
of the Man-6-P/IGF-II receptor colocalized with MPRs in 
intracellular  compartments.  These  results  are  consistent 
with the luminal domain of the Man-6-P/IGF-II receptor 
having  an  endosomal  retention  function.  Conibear  and 
Pearse (1994) came to a similar conclusion with their stud- 
ies of a chimera containing the cytoplasmic tail and trans- 
membrane domain of the Man-6-P/IGF-II receptor and a 
luminal domain of lysozyme. 
How might the cytoplasmic tail of the CD-MPR be func- 
tioning to prevent the receptor from entering lysosomes? 
The simplest explanation is that it contains a signal for the 
recruitment of the receptor into specialized subregions of 
the  endosomes that  give rise to vesicles destined  for the 
TGN and possibly the plasma membrane. The signal could 
function  by interacting  with  a  coat protein(s)  that  is  in- 
volved in vesicle formation. In the absence of this signal, 
the receptor would migrate to other subregions of the en- 
dosomes that either fuse directly with lysosomes or give 
rise to vesicles that fuse with these organelles. Either way, 
the  receptor  would  enter  a  lysosome  and  be  degraded. 
Amino acids 34-39  (CRSKPR)  of the cytoplasmic tail of 
the CD-MPR may constitute part or all of the signal. The 
finding that the deletion of increasing portions of the cyto- 
plasmic tail of the CD-MPR has an incremental effect on 
the  accumulation of the receptor in lysosomes may indi- 
cate that the signal is less potent if positioned close to the 
COOH-terminal end of the cytoplasmic tail (Mallabiabar- 
rena et al., 1995). An alternative explanation is that amino 
acids 34-39 determine a critical conformation of the cyto- 
plasmic tail that is required for the expression of a sorting 
signal located elsewhere in the cytoplasmic tail. The effect 
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this type of explanation. The lack of knowledge about the 
conformation  of  the  cytoplasmic  tail  of  the  CD-MPR 
makes it difficult to evaluate this possibility. Regardless, 
the important point is that the cytoplasmic tail contains a 
sorting  signal  that  serves  to  prevent trafficking to  lyso- 
somes and to facilitate transport of the receptor out of en- 
dosomes.  The  transmembrane  domain  of the  receptor, 
which also has a role in this process, might enhance the 
concentration of CD-MPR molecules in these specialized 
subregions of endosomes by mediating protein-protein in- 
teractions, with other CD-MPRs or with specific endoso- 
mal  membrane  proteins.  Alternatively,  the  transmem- 
brane domain could serve to position the cytoplasmic tail 
in such a way that the sorting determinant is optimally ex- 
pressed. 
Pfeffer and  her colleagues have  developed a  cell-free 
system for studying the transport of the Man-6-P/IGF-II 
receptor from late endosomes to Golgi membranes (Goda 
and Pfeffer, 1988,  1990; Draper et al.,  1990; Lombardi et 
al., 1993; Riederer et al.,  1994). Transport requires ATP, 
cytoplasmic factors, and Rab9, but does not appear to in- 
volve clathrin-coated vesicles, suggesting that a nonclath- 
rin coat protein may participate in this process. It would be 
of interest to determine if the Asp28Stop and MPR34-39A 
mutants fail to be transported in this reconstituted system. 
Based on the finding that the Man-6-P/IGF-II receptor 
and the low density lipoprotein receptor are transported 
from the cell surface to the Golgi complex at equal rates in 
PC12 cells, it has been suggested that receptor trafficking 
from late endosomes to the Golgi complex is a constitutive 
pathway followed by membrane proteins not actively re- 
tained in endosomes for delivery to lysosomes (Green and 
Kelly, 1992). However these kinetic studies do not exclude 
the possibility that the recycling receptors contain signals 
that direct transport from endosomes to the Golgi com- 
plex. Our data suggest that a specific sorting signal is re- 
quired, at least for this receptor. 
The finding that the CD-MPR contains a sorting deter- 
minant that prevents delivery to lysosomes may also be 
relevant to  the  trafficking of lysosomal membrane  pro- 
teins, such as Lamp1. These membrane proteins contain 
signals that mediate sorting in the Golgi complex and/or 
internalization at the plasma membrane, resulting in even- 
tual  delivery to  late  endosomes  (Sandoval  and  Bakke, 
1994). However, the movement of these proteins from late 
endosomes to lysosomes is poorly understood. Based on 
the findings reported here, it is possible that the lysosomal 
membrane proteins may pass from late endosomes to lyso- 
somes by a  default mechanism. Alternatively, these pro- 
teins may contain positive sorting determinants that direct 
movement from late endosomes to lysosomes. Evidence 
for a positive signal for the lysosomal delivery of the cell 
adhesion molecule P-selectin has been obtained by Green 
et al.  (1994). These investigators identified a short region 
in the cytoplasmic tail of P-selectin that promoted trans- 
port from endosomes to lysosomes, thereby providing a 
mechanism for down-regulating the surface expression of 
the molecule. Presumably this signal serves to retain the 
protein in early endosomes, thereby preventing recycling 
to the plasma membrane and allowing movement to late 
endosomes. However, whether it also directs the traffick- 
ing of the protein from late endosomes to lysosomes (ver- 
sus a default mechanism) remains to be shown. Interest- 
ingly, this stretch of 10 amino acids does not contain any 
obvious homology to the cytoplasmic tail sequences found 
in the known lysosomal membrane proteins, so the gener- 
ality of this mechanism remains to be established. 
While our experiments have focused on the CD-MPR, it 
seems likely that other recycling receptors will be found to 
contain signals in their cytoplasmic tails that prevent traf- 
ficking to lysosomes where they would be degraded. The 
approach taken in this study may prove useful in identify- 
ing these signals. 
We thank Dr. M. Fukuda and Dr. H.-P. Hauri for kindly providing anti- 
bodies  against  Lampl.  The  hybridoma  cell  line  producing  mAb  22d4 
against CD-MPR was a kind gift of Dr. D. Messner. Members of the Korn- 
feld laboratory are acknowledged for critical reading of the manuscript; 
Dr. D. Sch~fer for her initial help with the confocal microscope. 
This work was supported by United States Public Health Service grant 
CA 08759 and by a Monsanto/Washington University biomedical research 
grant. J. Rohrer was the recipient of a  Damon Runyon-Walter Winchell 
cancer postdoctoral fellowship (DRG  1216). A. Schweizer was supported 
by a W. M. Keck fellowship. 
Received for publication 15 May 1995 and in revised form 20 June 1995. 
References 
Balch, W. E., and J. E. Rothman. 1985. Characterization of protein transport 
between successive compartments of the Golgi apparatus: asymmetric prop- 
erties of donor and aeceptor activities in a cell-free system. Arch. Biochem. 
B iophys. 240:413~25. 
Canfield, W. M., K. F. Johnson, R. D. Ye, W. Gregory, and S. Kornfeld. 1991. 
Localization of the signal for rapid internalization of the bovine cation-inde- 
pendent  mannose  6-phosphate/insulin-like growth  factor-II  receptor  to 
amino acids 24-29 of the cytoplasmic tail. J. Biol. Chem. 266:5682-5688. 
Carlsson, S. R., J. Roth, F. Piller, and M. Fukuda. 1988. Isolation and character- 
ization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp- 
2. Major sialoglycoproteins carrying polylactosaminoglycan. J.  BioL  Chem. 
263:18911-18919. 
Chen, H. J., J. Remmler, J. C. Delaney, D. J. Messner, and P. Lobel. 1993. Mu- 
tational analysis of the  cation-independent mannose  6-phosphate/insulin- 
like growth factor II receptor. A  consensus casein kinase II site followed by 
2 leucines near the carboxyl terminus is important for intracellular  targeting 
of lysosomal enzymes. J. Biol. Chem. 268:22338-22346. 
Conibear, E., and B. M. Pearse. 1994. A  chimera of the cytoplasmic tail of the 
mannose 6-phosphate/IGF-II receptor and lysozyme localizes to the TGN 
rather than  prelysosomes where the  bulk of the  endogenous receptor  is 
found. J. Cell Sci. 107:923-932. 
Dintzis, S. M., and S. R. Pfeffer. 1990. The mannose 6-phosphate receptor cyto- 
plasmic domain is not sufficient to alter the cellular distribution of a chimeric 
EGF receptor. EMBO (Eur. Mol. Biol. Organ.) J. 9:77-84. 
Dintzis, S. M., V. E. Velculescu, and S. R. Pfeffer. 1994. Receptor extracellular 
domains may contain trafficking information. Studies of the 300-kDa man- 
nose 6-phosphate receptor. J. Biol. Chem. 269:12159-12166. 
Draper, R. K., Y. Goda, F. M. Brodsky, and S. R. Pfeffer. 1990. Antibodies to 
clathrin inhibit endocytosis but not recycling to the trans Golgi network in 
vitro. Science (Wash. DC). 248:1539-1541. 
Duncan, J. R., and S. Kornfeld. 1988. Intracellular movement of two mannose 
6-phosphate receptors: return to the Golgi apparatus. J. Cell Biol.  106:617-628. 
Fuhlbrigde, R. C., S. M. Fine, E. R. Unanue, and D. D. Chaplin. 1988. Expres- 
sion of membrane interleukin 1 by fibroblasts transfected with murine pro- 
interluekin 1(alpha) eDNA. Proc. Natl. Acad. Sci.  USA. 85:564%5653. 
Gabel, C. A., D, E. Goldberg, and S. Kornfeld. 1983. Identification and charac- 
terization of cells deficient in the mannose 6-phosphate receptor: evidence 
for an alternative pathway for lysosomal enzyme targeting. Proc. Natl. Acad. 
Sci.  USA. 80:775-779. 
Gasa, S., and S. Kornfeld. 1987. Studies of the biosynthesis of the cation-depen- 
dent mannose 6-phosphate receptor in murine cell lines. Arch.  Biochem. 
Biophys. 257:170-176. 
Goda, Y., and S. R. Pfeffer. 1988. Selective recycling of the mannose 6-phos- 
phate/IGF-II receptor to the trans Golgi network in vitro. Cell. 55:309-320. 
Goda, Y, and S. R. Pfeffer. 1991. Identification of a novel, N-ethylmaleimide- 
sensitive cytosolic factor required for vesicular transport from endosomes to 
the trans-Golgi network in vitro. J. Cell BioL 112:823~831. 
Green, S. A., and R. B. Kelly. 1992. Low density lipoprotein receptor and cat- 
ion-independent mannose 6-phosphate  receptor are transported from the 
cell surface to the Golgi apparatus at equal rates in PC12 cells. J.  Cell Biol. 
Rohrer et al. Endosomal Sorting of the Mannose 6-P Receptor  1305 117:47-55. 
Green, S. A., K.-P. Zimmer, G. Griffiths, and I. Mellman. 1987. Kinetics of in- 
tracellular transport and sorting of lysosomal membrane and plasma mem- 
brane proteins. J. Cell Biol. 105:1227-1240. 
Green, S. A., H. Setiadi, R. P. McEver, and R. B. Kelly. 1994, The cytoplasmic 
domain of P-selectin contains a sorting determinant that mediates rapid deg- 
radation in lysosomes. J. Cell BioL 124:435-448. 
Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site- 
directed mutagenesis by overlap extension using the polymerase chain reac- 
tion. Gene (Amst.). 77:51-59. 
Jadot, M., W. M. Canfield, W. Gregory, and S. Kornfeld. 1992. Characterization 
of the signal for rapid internalization of the bovine mannose 6-phosphate/in- 
sulin-like growth factor-If receptor. Z Biol. Chem. 267:11069-11077. 
Johnson, K. F., and S. Kornfeld. 1992a.  The cytoplasmic tail of the mannose 
6-phosphate/insulin-like  growth factor-II receptor has two signals for lysoso- 
real enzyme sorting in the Golgi J. Cell Biol. 119:249-257. 
Johnson, K. F., and S. Kornfeld. 1992b. A  His-Leu-Leu sequence near the car- 
boxyl terminus of the cytoplasmic domain of the cation-dependent mannose 
6-phosphate receptor is necessary for the lysosomal enzyme sorting function, 
Z  Biol. Chem. 267:17110-17115. 
Johnson, K. F., W.  Chan, and S. Kornfeld. 1990.  Cation-dependent mannose 
6-phosphate receptor contains two internalization signals in its cytoplasmic 
domain. Proc. Natl. Acad. Sci.  USA. 87:10010-10014. 
Klumperman, J., A. Hille, T. Veenendaal, V. Oorschot, W. Stoorvogel, K. von 
Figura, and H. J. Geuze. 1993. Differences in the endosomal distributions of 
the two mannose 6-phosphate receptors. J. Cell Biol. 121:997-1010. 
Kornfeld, S. 1992. Structure and function of the mannose 6-phosphate/insulin- 
like growth factor II receptors. Annu. Rev. Biochem. 61:307-330. 
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4. Nature (Lond.). 227:680-685. 
Lobel, P., K. Fujimoto, R. D. Ye, G. Griffiths, and S. Kornfeld. 1989. Mutations 
in the cytoplasmic domain of the 275-kd mannose 6-phosphate receptor dif- 
ferentially alter lysosomal enzyme sorting and endocytosis. CeIL 57:787-796. 
Lombardi, D., T. Soldati, M. A. Riederer, Y. Goda, M. Zerial, and S. R. Pfeffer. 
1993.  Rab9 functions in transport between late endosomes and the trans- 
Golgi network. EMBO (Eur. MoL Biol. Organ.) Z  12:677-682. 
Mallabiabarrena, A.,  M.  A. Jimrnez, M.  Rico, and B.  Alarern.  1995.  A  ty- 
rosine-containing motif mediates ER retention of CD3-e and adopts a helix- 
turn structure. EMBO (Eur MoL Biol. Organ.) J. 14:2257-2268. 
Messner, D. J. 1993. The mannose receptor and the cation-dependent form of 
mannose 6-phosphate receptor have overlapping cellular and subcellular  dis- 
tributions in liver. Arch. Biochem. Biophys. 306:391-401. 
Ogata, S., and M. Fukuda. 1994. Lysosomal targeting of Limp II membrane glyco- 
protein requires a novel Leu-Ile motif at a particular position in its cytoplas- 
mic tail. J. Biol. Chem. 269:5210-5217. 
Peters, C., M. Braun, B. Weber, M. Wendland, B. Schmidt, R. Pohlmann, A. 
Waheed, and K. von Figura. 1990. Targeting of a lysosomal membrane pro- 
tein: a tyrosine-containing endocytosis signal in the cytoplasmic tail of lyso- 
somal acid phosphatase  is necessary and sufficient for  targeting to  lyso- 
somes. EMBO (Eur. Mol. Biol. Organ.) J. 9:3497-3506. 
Riederer, M. A., T. Soldati, A. D. Shapiro, J. Lin, and S. R. Pfeffer. 1994. Lyso- 
some biogenesis requires rab9 function and receptor recycling from eudo- 
somes to the trans-Golgi network. J. Cell Biol. 125:573-582. 
Sandoval, I. V., and O. Bakke. 1994. Targeting of membrane proteins to endo- 
somes and lysosomes. Trends Cell Biol. 4:292-297. 
Sandoval, I. V., J. J. Arredondo, J. Alcalde, A. Gonzalez Noriega, J. Vande- 
kerckhove, M. A. Jimenez, and M. Rico. 1994.  The residues Leu(Ile)475- 
Ile(Leu, Val, Ala)476, contained in the extended carboxyl cytoplasmic tail, 
are critical for targeting of the resident lysosomal membrane protein LIMP 
II to lysosomes. J. Biol. Chem. 269:6622-6631. 
Sanger, F., S. Nicklen, and S.R. Coulson 1977. DNA sequencing with chain ter- 
minating inhibitors. Proc. Natl. Acad. Sci. USA. 74:5463-5471. 
Schulze-Garg, C., C. BOker, S. K. Nadimpalli, K. von Figura, and A. Hille-Reh- 
feld. 1993. Tail-specific antibodies that block return of 46,000 M r  mannose 
6-phosphate receptor to the trans-Golgi network. J. Cell Biol. 122:541-551. 
Schweizer, A., J. A. M. Fransen, T. Bachi, L. Ginsel, and H.-P.  Hauri.  1988. 
Identification, by a monoclonal antibody, of a 53-kD protein associated with 
a tubulo-vesicular compartment at the cis-side of the Golgi apparatus. J. Cell 
Biol. 107:1643-1653. 
Towbin, H., T. Stachelin, and J. Gordon. 1979. Electrophoretic transfer of pro- 
teins from polyacrylamide gels to nitrocellulose sheets: procedure and some 
applications. Proc. Natl. Acad. Sci.  USA. 76:4350-4354. 
Williams, M. A., and M. Fukuda. 1990. Accumulation of membrane glycopro- 
teins in lysosomes requires a tyrosine residue at a particular position in the 
cytoplasmic tail. J. Cell Biol. 111:955-966. 
The Journal of Cell Biology, Volume 130,  1995  1306 